Survival Benefit of Adjuvant Radiation Therapy for Gastric Cancer following Gastrectomy and Extended Lymphadenectomy

Survival Benefit of Adjuvant Radiation Therapy for Gastric Cancer following Gastrectomy and Extended Lymphadenectomy

Purpose. Although randomized trials suggest a survival benefit of adjuvant chemotherapy and radiation therapy (XRT) for gastric adenocarcinoma, its use in patients who undergo an extended lymphadenectomy is less clear. The purpose of this study was to determine if a survival benefit exists in gastri...

Full description

Bibliographic Details
Main Authors:	R. A. Snyder, E. T. Castaldo, C. E. Bailey, S. E. Phillips, A. B. Chakravarthy, N. B. Merchant
Format:	Article
Language:	English
Published:	Hindawi Limited 2012-01-01
Series:	International Journal of Surgical Oncology
Online Access:	http://dx.doi.org/10.1155/2012/307670

Similar Items

Time-related improvement of survival in resectable gastric cancer: the role of Japanese-style gastrectomy with D2 lymphadenectomy and adjuvant chemotherapy
by: Vidal Oscar, et al.
Published: (2006-08-01)

Indirect Comparison Showed Survival Benefit from Adjuvant Chemoradiotherapy in Completely Resected Gastric Cancer with D2 Lymphadenectomy
by: Qiong Yang, et al.
Published: (2013-01-01)

Survival benefit with extended lymphadenectomy for advanced renal malignancy: A population-based analysis
by: Dean Laganosky, et al.
Published: (2020-01-01)

The quality of life after a total gastrectomy with extended lymphadenectomy and omega type oesophagojejunostomy for gastric adenocarcinoma without distant metastases
by: Jakstaite Gintare, et al.
Published: (2012-06-01)

Adjuvant chemotherapy is an additional option for locally advanced gastric cancer after radical gastrectomy with D2 lymphadenectomy: a retrospective control study
by: Lei Chen, et al.
Published: (2021-08-01)

Laparoscopic gastrectomy with D2 lymphadenectomy for gastric cancer: initial Egyptian experience at the National Cancer Institute
by: Mohamed Aly Abdelhamed, et al.
Published: (2020-02-01)

The Survival Benefit and Safety of Splenectomy for Gastric Cancer With Total Gastrectomy: Updated Results†
by: Kun Yang, et al.
Published: (2021-01-01)

RADICAL PROSTATECTOMY WITH EXTENDED PELVIC LYMPHADENECTOMY AND ADJUVANT HORMONAL THERAPY IN PATIENTS WITH LYMPHOGENIC DISSEMINATED PROSTATE CANCER
by: B. Ya. Alekseev, et al.
Published: (2014-08-01)

RADICAL PROSTATECTOMY WITH EXTENDED PELVIC LYMPHADENECTOMY AND ADJUVANT HORMONAL THERAPY IN PATIENTS WITH LYMPHOGENIC DISSEMINATED PROSTATE CANCER
by: B. Ya. Alekseev, et al.
Published: (2014-08-01)

Gastrectomy and D2 Lymphadenectomy for Gastric Cancer: A Meta-Analysis Comparing the Harmonic Scalpel to Conventional Techniques
by: Hang Cheng, et al.
Published: (2015-01-01)

The effect of fibrin glue on the postoperative lymphatic leakage after D2-lymphadenectomy and gastrectomy in patients with gastric cancer
by: Habibollah Mahmoodzadeh, et al.
Published: (2021-03-01)

Laparoscopic gastrectomy plus D2 lymphadenectomy is as effective as open surgery in terms of long-term survival: a single-institution study on gastric cancer
by: Yawei Wang, et al.
Published: (2021-04-01)

“Sandwich” infrapyloric lymphadenectomy in laparoscopic radical gastrectomy: A video vignette
by: Xijie Zhang, et al.
Published: (2021-08-01)

Nationwide study of the impact of D2 lymphadenectomy on survival after gastric cancer surgery
by: C.‐H. Kung, et al.
Published: (2020-06-01)

Adjuvant chemotherapy for elderly patients with gastric cancer after D2 gastrectomy.
by: Ying Jin, et al.
Published: (2013-01-01)

Lymphadenectomy using two instrument arms during robotic surgery for gastric cancer: A strategy to facilitate reduced-port robotic gastrectomy
by: Yong Yeup Kim, et al.
Published: (2020-03-01)

Laparoscopic extended lymphadenectomy for bladder and prostate cancer
by: Anibal W. Branco, et al.
Published: (2010-10-01)

Clinical usefulness of extending the proximal margin in total gastrectomies for gastric adenocarcinoma
by: U. Clemente-Gutiérrez, et al.
Published: (2019-04-01)

D2 Lymphadenectomy in Gastric Cancer Surgery
by: Jingyu DENG, et al.
Published: (2009-06-01)

Favoring D2-Lymphadenectomy in Gastric Cancer
by: Ioannis Karavokyros, et al.
Published: (2018-06-01)

Survival Benefits of Simple Versus Extended Cholecystectomy and Lymphadenectomy for Patients With T2 Gallbladder Cancer: A Propensity-Matched Population-Based Study (2010 to 2015)
by: Wei Zhang, et al.
Published: (2021-08-01)

Is There Any Role for D3 Lymphadenectomy in Gastric Cancer?
by: Gerassimos N. Douridas, et al.
Published: (2018-03-01)

Long-term survival differences in gastric cancer after D2 lymphadenectomy and an improved assessment of resectability
by: Gabriel Dimofte, et al.
Published: (2017-05-01)

Robotic-assisted versus conventional laparoscopic-assisted total gastrectomy with D2 lymphadenectomy for advanced gastric cancer: short-term outcomes at a mono-institution
by: Shan-ping Ye, et al.
Published: (2019-07-01)

Significance of Microscopic Residual Tumor in Adenocarcinoma of Stomach and Esophagogastric Junction after Gastrectomy with D2 Lymphadenectomy
by: Thammawat Parakonthun, et al.
Published: (2018-06-01)

Significance of Microscopic Residual Tumor in Adenocarcinoma of Stomach and Esophagogastric Junction after Gastrectomy with D2 Lymphadenectomy
by: Thammawat Parakonthun, M.D., et al.
Published: (2018-04-01)

Laparoscopic Gastrectomy with D2 Lymphadenectomy for pT1a Adenocarcinoma: Case Report and Literature Review
by: Cristina Dan, et al.
Published: (2020-02-01)

Survival benefits of simple versus extended cholecystectomy and lymphadenectomy for patients with T1b gallbladder cancer: An analysis of the surveillance, epidemiology, and end results database (2004 to 2013)
by: Li Xu, et al.
Published: (2020-06-01)

Adjuvant chemo-radiation for gastric adenocarcinoma: an institutional experience
by: Ghosn Marwan G, et al.
Published: (2010-06-01)

Current controversies and consensus on extended lymphadenectomy in renal cell carcinoma
by: R M Sathishkumar
Published: (2012-01-01)

Central lymph node metastasis is predictive of survival in advanced gastric cancer patients treated with D2 lymphadenectomy
by: Huiwen Lu, et al.
Published: (2021-01-01)

Survival of proper hepatic artery lymph node metastasis in patients with gastric cancer: implications for D2 lymphadenectomy.
by: Cai Shirong, et al.
Published: (2015-01-01)

Comparison of totally laparoscopic and open approach in total gastrectomy with D2 lymphadenectomy – systematic review and meta-analysis
by: Małczak P, et al.
Published: (2018-12-01)

The optimal extent of gastrectomy for middle-third gastric cancer: distal subtotal gastrectomy is superior to total gastrectomy in short-term effect without sacrificing long-term survival
by: Xin Ji, et al.
Published: (2017-05-01)

Prognosis of Adjuvant SOX vs XELOX Chemotherapy for Gastric Cancer After D2 Gastrectomy in Chinese Patients
by: Yu S, et al.
Published: (2020-10-01)

Comparison of capecitabine and oxaliplatin with S-1 as adjuvant chemotherapy in stage III gastric cancer after D2 gastrectomy.
by: Jang Ho Cho, et al.
Published: (2017-01-01)

Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial
by: Jie Shen, et al.
Published: (2018-08-01)

Adjuvant chemoradiotherapy after d2-lymphadenectomy for gastric cancer: the role of n-ratio in patient selection. results of a single cancer center
by: Costa Wilson L, et al.
Published: (2012-10-01)

Chylous Fistula following Axillary Lymphadenectomy: Benefit of Octreotide Treatment
by: Elena González-Sánchez-Migallón, et al.
Published: (2016-01-01)

Nomograms for predicting survival in patients with metastatic gastric adenocarcinoma who undergo palliative gastrectomy
by: Tai Ma, et al.
Published: (2019-08-01)

Cannot write session to /tmp/vufind_sessions/sess_1ac5n3h5dm961ehuccq93j5qr0